Meiragtx
MeiraGTx Holdings plc is a clinical‑stage gene‑therapy company advancing AAV‑based treatments for inherited retinal diseases, Parkinson’s, and xerostomia. Partners with Johnson & Johnson and Hologen, targeting high‑growth rare‑disease markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 409
- HQ: New York
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.